References
- Sørensen A, Jespersen S, Katzenstein TL, et al. Clinical presentation and opportunistic infections in HIV-1, HIV-2 and HIV-1/2 dual seropositive patients in Guinea-Bissau. Infect Dis (London). 2016;48:604–6011.
- WHO. Global tuberculosis report 2018. Geneva: World Health Organization; 2018. Licence: CC BY-NC-SA 3.0 IGO.
- Alagna R, Diaw MM, Centis R, et al. Universal health coverage and social support in Senegal: a comprehensive approach against tuberculosis. Eur Respir J. 2015;46:869–871.
- Dhoot R, Humphrey JM, O'Meara P, et al. Implementing a mobile diagnostic unit to increase access to imaging and laboratory services in western Kenya. BMJ Glob Health. 2018;3:e000947.
- Cazabon D, Pande T, Kik S, et al. Market penetration of Xpert MTB/RIF in high tuberculosis burden countries: a trend analysis from 2014–2016. Gates Open Res. 2018;2:35.
- Diaw MM, Ndiaye M, Riccardi N, et al. StopTB Italia Onlus. Implementing TB control in a rural, resource-limited setting: the stop-TB Italia project in Senegal. Multidiscip Respir Med. 2018;13:41.
- Hargreaves JR, Boccia D, Evans CA, et al. The social determinants of tuberculosis: from evidence to action. Am J Public Health. 2011;101:654–662.
- Diel R, Loddenkemper R, Zellweger JP, et al. Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination. Eur Respir J. 2013; 42:785–801.
- Basera TJ, Ncayiyana J, Engel ME. Prevalence and risk factors of latent tuberculosis infection in Africa: a systematic review and meta-analysis protocol. BMJ Open. 2017;7:e012636.
- Fox GJ, Dobler CC, Marais BJ, et al. Preventive therapy for latent tuberculosis infection-the promise and the challenges. Int J Infect Dis. 2017;56:68–76.